I updated this to reflect some extra detail that is now available. The clinical trial covered 309 patients at 21 institutions. The 5 year progression-free survival was:
• low risk- 97%
• favorable intermediate risk- 100%
• unfavorable intermediate risk - 93%
These excellent results were achieved without adding hormone therapy and are similar to results achieved for conventional IMRT with hormone therapy.
There were very low rates of late-term serious side effects (0% rectal, 1% urinary).
There are ongoing clinical trials for SBRT use with high risk prostate cancer.
While it generally doesn't make sense to use sbrt for metastatsic cancer, but if you have a metastatsis in a strategic location such as a vertebrae, then it may make sense.
I agree that using SBRT for metastasis-directed therapy may make sense in certain situations, but that is a completely different situation and a topic not addressed by this study. I know this is off-topic for an advanced cancer board, but I didn't know where else to post it. Perhaps Darryl will someday start a separate board for localized and pre-diagnosis PC.
What are your thoughts about SBRT to pelvic bed and surrounding lymph nodes with NO ADT for node positive (4 of 10 post operative pathology report in April 2016).
I Just had PSMA scan -CT scan and bone scan August 2018 -- all were negative.
PSA immediately after surgery was 0.03 PSA currently 0.6
Only taking Avadart and OTC supplements for last 8 months -- nothing else.
SBRT is a way to get the biologically effective radiation dose higher without increasing toxicity. I know that Dr King's ongoing clinical trial where he treats the prostate (8 Gy x 5 treatments) and all the pelvic lymph nodes with SBRT (5 Gy x 5 treatments) doesn't seem to incur any undue toxicity, at least so far in the first year. After a few more years of data are in, I think it will become a standard of care.
There is some controversy about this. Dr Dottoli, for example, takes the opposite tack. He uses very low doses of about 1.5 Gy over an extended time period to treat the pelvic lymph nodes.
SBRT CAN be given as a WPRT to men with detected cancerous lymph nodes (N1) - either as salvage radiation (see George71's comment above) or as primary therapy. But I haven't seen any large scale studies of it. I did review the observational studies of salvage IMRT for N1:
Fiducials are used for both IMRT and SBRT. They (usually 3) can be inserted either rectally or transperineally (which lowers infection risk). It is a minimal procedure, much like a mini-biopsy. What is your concern?
The pain was intense ,rectal bleeding and difficulties to urinate for ten days after the biopsy.
In addition the adverse reaction list of fiducial markers implantation is no fun neither.
Those are my concerns.
But life has a funny way to ease our concerns : it gives us a greater concern to deal with.
Up until this morning it was the gold seeds, and then I got a phone call from a genetics consultant secretary to set up a meeting tomorrow.He wants to see me after been checked for BRCA 1/2. I guess I'm not going to hear good news tomorrow
For others, there is now an inexpensive test ($250) called Color Genomics that checks for BRCA mutations and a host others. There are also lists of clinical trials using PARP inhibitors and Platins:
I am one the first group of patients (#4 or 5) that joined the clinical trial at UT Southwestern, Dallas, TX headed by Dr Timmerman in early 2007. For me it did not work because at the time, unbeknown to me then, my PC has already metastasized elsewhere but not detectable by any standard scans. PSA never nadir-ed below 5. I do think that for those with G3+3 or less this procedure (5 high dose radiation in one week) is equivalent to IMRT (40+ standard radiation). PSA was near 15, G4+3, T1C prior to trial start. I was dropped from the study result. My take is that SBRT is an alternate to IMRT with similar outcome, IF the cancer is not already elsewhere. If it has already metastasized, then it is just a matter of time before the cancer returns.
I'm sorry it wasn't curative, but it MAY have slowed your cancer down - it's hard to say. With PET scans getting better, perhaps it will someday become routine to screen unfavorable risk patients.
Tall_Allen, do you think i could be a candidate for this SBRT treatment. I will be going for the lutetium 177 treatment here soon but i will give you the latest MO report. It reads...PSA now at 17 & he has PSA positive recurrent desease in the prostatic bed as well as in the lymph nodes in the pelvis and retroperitoneum up the renal helum and also the left supraclavicular fossa.He has no evidence of psma osseous or other solid organ disease.
I might add i have not been on any ADT treatment for 6 weeks now & the psa rising therefore.
SBRT isn't the right treatment, as far as we know, for salvage radiation for a recurrence after prostatectomy. You might be better off with salvage whole pelvic IMRT. Talk to a radiation oncologist.
Dear Tall Allen, , I don't know if you can help me. Ive written to you before. At 59 I was diagnosed with PC a. PSA was 31, Gleason 9 doubling every 5 months. I'm a twin and he was diagnosed the same week. His was operable, Gleason 7. I was told I was M1 distant metastasis. I had 3 bone mets, one on L1 one on scapula, one on t3. I was put on Lupron and 2 weeks on Casodex for flare. I did Lupron for 2.5 years then psa went up from .1 twice. I took every conceivable supplement I could afford. The I signed on at NIH for Xtandi or Xtandi and Prostvac (a fowl pox vaccine). I got in the Xtandi alone arm of the trial. I've been 3 years now on Xtandi and Lupron at NIH (no supplements since trial). Since Xtandi and Lupron I've had a PSA of .02 undetectable. All 3 bone mets not visible. A few lymph nodes oversized now normal. I've read about John Hopkins is messing with high doses of testosterone. The article talked about a cure this way. Do you know anything about it? If you were getting good results from Lupron and Xtandi would you sit back and enjoy the ride. I'm 65 now.
No one at JH is talking about a cure for metastatic PC with testosterone. For some men, it's a way to prolong hormone sensitivity. You can read about it here:
just finished first year of SBRT. PSA started before treatment with 3.5, - 5 cores, none more then 30% , diagnosed with low intermediate. 1st follow up 3mo 1.9, second follow up 3mo
was .9, but third follow up 1.28 and 3months later 1.54(now). The Urologist says he is not
concerned. Should I be? Perhaps the SBRT did not work
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
66 year old father - prostate cancer spread to pelvis - advice please
Interesting report on the efficacy of IMRT on prostate cancer
Article: ADT May Increase Risk of Death From Cardiovascular Disease in Prostate Cancer
